|Salary:||£31,866 to £36,914 per annum (Grade 7)|
|Placed On:||23rd February 2021|
|Closes:||24th March 2021|
Contract Type: Fixed-term for 2 years.
An exciting opportunity has arisen for a Research Associate in the Sheffield Institute for Translational Neuroscience (SITraN). SITraN is a purpose built research facility which was opened in November 2010 by Her Majesty the Queen and awarded the Queen’s Anniversary prize for higher education in 2020 in recognition of having made an outstanding positive impact in patient’s lives. The Institute houses clinical and basic scientists from the Department of Neuroscience and the primary focus is research into neurodegenerative disorders such as Motor Neurone Disease (MND), Parkinson’s disease and Alzheimer’s disease.
We are seeking an enthusiastic and experienced Research Associate to join an exciting translational research project funded by the Medical Research Council (MRC). The successful candidate will join a dynamic research team under the joint supervision of Dr Laura Ferraiuolo, Prof Pamela Shaw and Dr Richard Mead in collaboration with the Pharma company AclipseOne. The project will focus on developing a patient stratification approach for MND based on drug response by using patient-derived cells (neurons and astrocytes) and biosamples, such as blood, in combination with transcriptomics.
The candidate should be passionate about neurodegenerative disease research, ideally with a track record of translational research in this area.
You should have a PhD (or be close to completion) in molecular or cellular biology, or neuroscience (or equivalent experience). You will have a strong background in molecular and cellular (neuro) biology with experience in a range of molecular and cellular biology techniques. Your role will be embedded in very dynamic research groups. Team spirit and an impeccable work ethics are essential.
You will be joining the laboratories of Dr Laura Ferraiuolo and Prof Pamela Shaw; to work at the cutting edge of neurodegenerative disease research using a range of methods for translational drug development and patient stratification research. The position is in collaboration with AclipseOne and will specifically investigate strategies for patient stratification based on in vitro individual response to an anti-oxidant drug developed for clinical trial in MND.
We’re one of the best not-for-profit organisations to work for in the UK. The University’s Total Reward Package includes a competitive salary, a generous Pension Scheme and annual leave entitlement, as well as access to a range of learning and development courses to support your personal and professional development.
We build teams of people from different heritages and lifestyles from across the world, whose talent and contributions complement each other to greatest effect. We believe diversity in all its forms delivers greater impact through research, teaching and student experience.
To find out what makes the University of Sheffield a remarkable place to work, watch this short film: www.youtube.com/watch?v=7LblLk18zmo, and follow @sheffielduni and @ShefUniJobs on Twitter for more information.
Apply now by clicking on the Apply button located near the top of your screen.
Type / Role: